Evaluation and Management of the Patient with Hypertension and Hypokalemia - PowerPoint PPT Presentation

About This Presentation
Title:

Evaluation and Management of the Patient with Hypertension and Hypokalemia

Description:

Title: Evaluation and Management of the Patient with Hypertension and Hypokalemia Author: x Last modified by: x Created Date: 4/19/2005 4:09:42 AM – PowerPoint PPT presentation

Number of Views:382
Avg rating:3.0/5.0
Slides: 23
Provided by: X464
Category:

less

Transcript and Presenter's Notes

Title: Evaluation and Management of the Patient with Hypertension and Hypokalemia


1
Evaluation and Management of the Patient with
Hypertension and Hypokalemia
  • Stephen L. Aronoff, MD

2
When to Expect Mineralocorticoid Excess
  • Hypertension
  • Hypokalemia
  • Metabolic alkalosis
  • Less than 50 with Primary Aldosteronism are
    hypokalemia

3
Differential Diagnosis of Hypokalemia and normal
BP
  • Surreptitious vomiting
  • Bartters Syndrome
  • Rare primary aldosteronism

4
Other Causes of Hypertension and Hypokalemia
  • Renovascular Disease
  • Diuretic therapy
  • Cushings Syndrome
  • Licorice ingestion
  • CAH
  • Rare renin-secreting tumors

5
When to Screen Patient for Primary Aldosteronism
  • Hypokalemia
  • Severe, resistant or relatively acute HT
  • Adrenal incidentaloma
  • Primary aldosteronism occurs in 1-2 up to 5-10
    of all hypertensives probably an over-estimate

6
Consider screening Hypertensive patients under 30
for secondary causes
  • With mild to severe hypertension
  • No FH of hypertension
  • Non-obese

7
Initial Approach to Patient with HT and
Hypokalemia
  • Plasma renin activity
  • Plasma aldosterone concentration

8
Plasma Renin Activity in Hypokalemia and HT
  • Low
  • Primary mineralocorticoid excess
  • High
  • Diuretic therapy
  • Reno-vascular HT
  • Malignant HT
  • Rare renin-secreting tumor

9
Plasma Aldosteronism/Plasma Renin Activity
  • Test in AM
  • Un-interpretable with spironolactone or
    eplerenone RX stop for 6 weeks
  • Other K diuretics OK
  • ACEI and ARBs may falsely elevate PRA
  • (undetectable PRA strongly suggestive)

10
Plasma Aldosteronism/Plasma Renin Activity
  • Normal ratio 4 10
  • Primary aldosteronism 30 50
  • PRA low in many with essential HT but high PAC
    (gt15 ng/dl) and abnormal ratio are uncommon
  • Cut-off for high PAC/PRA is lab dependent. Thus
    increased PAC is part of dx requirement

11
Other Lab Testing
  • 24 hour urine Potassium usually not necessary
    to demonstrate K wasting
  • Unless PRA not suppressed
  • PAC not elevated
  • Clinical suspicion of surreptitious vomiting or
    laxative abuse
  • Inappropriate K wasting is gt 30mg daily in
    hypokalemic patient
  • Urine Na gt 50meq daily

12
Confirmation of Primary Aldosteronism
  • Elevated PAC/PRA
  • Salt load (after control of HT and correction of
    K)
  • Dietary for 3 days
  • 5000mg Na diet or 1gm NaCl tablets 2 tid
  • Watch out for worsening HT and hypokalemia

13
Confirmation of Primary Aldosteronism Contd
  • 3rd day of high salt diet collect 24 hr urine
    for aldosterone, sodium and creatinine
  • 24 hr urine Na should be gt 200meq to show
    adequate Na loading
  • Urine aldosterone gt 14 mcg/24 hrs consistent with
    primary hyperaldosteronism

14
Confirmation of Primary Aldosteronism Contd
  • IV sodium chloride
  • Baseline plasma aldosterone level
  • 2 liters NS IV over 4 hours
  • Repeat plasma aldosterone level
  • Primary hyperaldosteronism plasma aldosterone
    level does not suppress

15
Nonaldosterone Mineralocorticoid Excess
  • Suppressed PRA and low plasma or urine
    aldosterone value
  • Causes
  • Some types of CAH or familial cortisol
    resistance
  • Chronic licorice ingestion
  • Severe cases of Cushings syndrome
  • Deoxycorticosterone producing tumor

16
Familial Hyperaldosteronism
  • Type 1 glucocorticoid-remediable aldosteronism
  • Secondary to ACTH stimulation of aldosterone
    secretion
  • Type 2 not ACTH dependent and not suppressible
    with dexamethasone
  • Genetic defect unknown
  • They can have APA or IPA or both

17
Differentiating Adrenal Adenoma from Hyperplasia
  • 30 60 Adrenal adenomas
  • APA have higher aldosterone secretion rates
  • Adrenal hyperplasia less severe with less
    hypokalemia
  • PAC/PRA gt 32 had 100 sensitivity and 61
    specificity for APA in one study

18
Differentiating Adrenal Adenoma from Hyperplasia
  • Patients with APA
  • More severe HT
  • More profound hypokalemia - lt 3.0
  • Higher plasma (gt25 ng/dl) and urinary (gt30
    mcg/24 hrs) levels of aldosterone
  • Younger - lt 50

19
Differentiating Adrenal Adenoma from
HyperplasiaRadiographic Tests
  • Hypo-dense unilateral macroadenoma (gt1 cm) likely
    APA
  • Abnormality in both glands likely hyperplasia
    although both glands my appear normal on CT or MRI

20
Differentiating Adrenal Adenoma from
HyperplasiaRadiographic Tests
  • Some investigators suggest low K,
    nonsuppressible hyperaldosteronism, PAC/PRA ratio
    gt 50 and a unilateral mass can go directly to
    surgery
  • But in 3 studies of 32 pts. 11 patients (1/3)
    had bilateral hyperplasia
  • Absence of mass does not exclude APA
  • Bilateral lesions do not exclude APA
  • CT may be accurate only 50 of time

21
Differentiating Adrenal Adenoma from
HyperplasiaAdrenal Vein Sampling
  • Gold standard
  • APA - gt4 fold step-up of PAC
  • Best performed with continuous infusion of ACTH
    (50 mcg per hour)
  • Measure cortisol in same sample to be sure
    samples from adrenal veins
  • Cortisol from right adrenal 25 higher and 10
    times higher than peripheral vein

22
Differentiating Adrenal Adenoma from
HyperplasiaAdrenal Vein Sampling
  • Most useful when no adrenal abnormality
  • Both adrenal glands abnormal but asymmetric
  • One study 41 with normal CT and 49 with
    bilateral micronodules on CT had unilateral APA
  • In 203 pts. with primary aldosteronism 51 with
    unilateral micro-nodule and 66 with unilateral
    macro-nodule had ipsilateral aldo hypersecretion
Write a Comment
User Comments (0)
About PowerShow.com